{"entity":{"type":"insider","cik":"0001252522","url":"/insider/0001252522","json_url":"/insider/0001252522.json","name":"GALAKATOS NICHOLAS","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":215,"n_filings":124,"first":"2004-02-23","last":"2018-10-02","span_basis":"filed_date"},"name_variants":[{"name":"GALAKATOS NICHOLAS","source":"filing","n_filings":124,"first_seen":"2004-02-23","last_seen":"2018-10-02"}],"transactions":[{"id":6456241,"accession":"0001209191-18-053536","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-18-053536","line_url":"/filing/0001209191-18-053536#line-4","is_derivative":false,"issuer_cik":"0001252522","issuer_name":"Entasis Therapeutics Holdings Inc.","issuer_ticker":"ETTX","issuer_name_source":null,"issuer_url":"/issuer/0001252522","owner_cik":"0001252522","owner_name":"GALAKATOS NICHOLAS","owner_display_name":"GALAKATOS NICHOLAS","owner_url":"/insider/0001252522","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":453395.0,"shares_display":"453,395","price_per_share":15.0,"price_display":"15.00","price_state":"stated","total_value":6800925.0,"total_display":"6,800,925.00","total_whole":"6,800,925","shares_owned_after":1623405.0,"shares_owned_after_display":"1,623,405","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-09-28","filed_date":"2018-10-02","scope":"insider"},{"id":6212991,"accession":"0001401708-18-000121","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001401708-18-000121","line_url":"/filing/0001401708-18-000121#line-1","is_derivative":false,"issuer_cik":"0001252522","issuer_name":"NanoString Technologies Inc","issuer_ticker":"NSTG","issuer_name_source":null,"issuer_url":"/issuer/0001252522","owner_cik":"0001252522","owner_name":"GALAKATOS NICHOLAS","owner_display_name":"GALAKATOS NICHOLAS","owner_url":"/insider/0001252522","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":85823.0,"shares_display":"85,823","price_per_share":15.99,"price_display":"15.99","price_state":"stated","total_value":1372309.77,"total_display":"1,372,309.77","total_whole":"1,372,310","shares_owned_after":4036025.0,"shares_owned_after_display":"4,036,025","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-09-17","filed_date":"2018-09-19","scope":"insider"},{"id":6000319,"accession":"0001209191-18-040426","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-18-040426","line_url":"/filing/0001209191-18-040426#line-4","is_derivative":false,"issuer_cik":"0001249153","issuer_name":"Forty Seven, Inc.","issuer_ticker":"FTSV","issuer_name_source":null,"issuer_url":"/issuer/0001249153","owner_cik":null,"owner_name":"Clarus Ventures III GP, L.P.; WHEELER KURT; LIPTAK ROBERT; Requadt Scott; GALAKATOS NICHOLAS; Simon Nicholas; HENNER DENNIS; Clarus Lifesciences III, L.P.; Clarus Ventures III, LLC","owner_display_name":"Clarus Ventures III GP, L.P.","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":200000.0,"shares_display":"200,000","price_per_share":16.0,"price_display":"16.00","price_state":"stated","total_value":3200000.0,"total_display":"3,200,000.00","total_whole":"3,200,000","shares_owned_after":3816951.0,"shares_owned_after_display":"3,816,951","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-07-02","filed_date":"2018-07-02","scope":"insider"},{"id":2503803,"accession":"0001012975-16-000991","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001012975-16-000991","line_url":"/filing/0001012975-16-000991#line-2","is_derivative":false,"issuer_cik":"0001166285","issuer_name":"TETRALOGIC PHARMACEUTICALS CORP","issuer_ticker":"TLOG","issuer_name_source":null,"issuer_url":"/issuer/0001166285","owner_cik":null,"owner_name":"Clarus Lifesciences II, L.P.; LIPTAK ROBERT; WHEELER KURT; HENNER DENNIS; Simon Nicholas; Clarus Ventures II GP, L.P.; STEINMETZ MICHAEL; Clarus Ventures II, LLC; GALAKATOS NICHOLAS","owner_display_name":"Clarus Lifesciences II, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":230507.0,"shares_display":"230,507","price_per_share":0.16,"price_display":"0.16","price_state":"stated","total_value":36881.12,"total_display":"36,881.12","total_whole":"36,881","shares_owned_after":2214523.0,"shares_owned_after_display":"2,214,523","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-02-09","filed_date":"2016-02-10","scope":"insider"},{"id":2503797,"accession":"0001012975-16-000991","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001012975-16-000991","line_url":"/filing/0001012975-16-000991#line-1","is_derivative":false,"issuer_cik":"0001166285","issuer_name":"TETRALOGIC PHARMACEUTICALS CORP","issuer_ticker":"TLOG","issuer_name_source":null,"issuer_url":"/issuer/0001166285","owner_cik":null,"owner_name":"Clarus Lifesciences II, L.P.; LIPTAK ROBERT; WHEELER KURT; HENNER DENNIS; Simon Nicholas; Clarus Ventures II GP, L.P.; STEINMETZ MICHAEL; Clarus Ventures II, LLC; GALAKATOS NICHOLAS","owner_display_name":"Clarus Lifesciences II, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":103123.0,"shares_display":"103,123","price_per_share":0.19,"price_display":"0.19","price_state":"stated","total_value":19593.37,"total_display":"19,593.37","total_whole":"19,593","shares_owned_after":2445030.0,"shares_owned_after_display":"2,445,030","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-02-08","filed_date":"2016-02-10","scope":"insider"},{"id":3355598,"accession":"0001012975-16-000980","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001012975-16-000980","line_url":"/filing/0001012975-16-000980#line-3","is_derivative":false,"issuer_cik":"0001166285","issuer_name":"TETRALOGIC PHARMACEUTICALS CORP","issuer_ticker":"TLOG","issuer_name_source":null,"issuer_url":"/issuer/0001166285","owner_cik":null,"owner_name":"Simon Nicholas; STEINMETZ MICHAEL; Clarus Lifesciences II, L.P.; HENNER DENNIS; LIPTAK ROBERT; Clarus Ventures II GP, L.P.; WHEELER KURT; Clarus Ventures II, LLC; GALAKATOS NICHOLAS","owner_display_name":"Simon Nicholas","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":832881.0,"shares_display":"832,881","price_per_share":0.2,"price_display":"0.20","price_state":"stated","total_value":166576.2,"total_display":"166,576.20","total_whole":"166,576","shares_owned_after":2548153.0,"shares_owned_after_display":"2,548,153","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-02-05","filed_date":"2016-02-05","scope":"insider"},{"id":3355595,"accession":"0001012975-16-000980","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001012975-16-000980","line_url":"/filing/0001012975-16-000980#line-2","is_derivative":false,"issuer_cik":"0001166285","issuer_name":"TETRALOGIC PHARMACEUTICALS CORP","issuer_ticker":"TLOG","issuer_name_source":null,"issuer_url":"/issuer/0001166285","owner_cik":null,"owner_name":"Simon Nicholas; STEINMETZ MICHAEL; Clarus Lifesciences II, L.P.; HENNER DENNIS; LIPTAK ROBERT; Clarus Ventures II GP, L.P.; WHEELER KURT; Clarus Ventures II, LLC; GALAKATOS NICHOLAS","owner_display_name":"Simon Nicholas","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":500026.0,"shares_display":"500,026","price_per_share":0.14,"price_display":"0.14","price_state":"stated","total_value":70003.64,"total_display":"70,003.64","total_whole":"70,004","shares_owned_after":3381034.0,"shares_owned_after_display":"3,381,034","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-02-04","filed_date":"2016-02-05","scope":"insider"},{"id":3355591,"accession":"0001012975-16-000980","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001012975-16-000980","line_url":"/filing/0001012975-16-000980#line-1","is_derivative":false,"issuer_cik":"0001166285","issuer_name":"TETRALOGIC PHARMACEUTICALS CORP","issuer_ticker":"TLOG","issuer_name_source":null,"issuer_url":"/issuer/0001166285","owner_cik":null,"owner_name":"Simon Nicholas; STEINMETZ MICHAEL; Clarus Lifesciences II, L.P.; HENNER DENNIS; LIPTAK ROBERT; Clarus Ventures II GP, L.P.; WHEELER KURT; Clarus Ventures II, LLC; GALAKATOS NICHOLAS","owner_display_name":"Simon Nicholas","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":82583.0,"shares_display":"82,583","price_per_share":0.15,"price_display":"0.15","price_state":"stated","total_value":12387.45,"total_display":"12,387.45","total_whole":"12,387","shares_owned_after":3881060.0,"shares_owned_after_display":"3,881,060","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-02-03","filed_date":"2016-02-05","scope":"insider"},{"id":2503793,"accession":"0001012975-16-000957","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001012975-16-000957","line_url":"/filing/0001012975-16-000957#line-3","is_derivative":false,"issuer_cik":"0001166285","issuer_name":"TETRALOGIC PHARMACEUTICALS CORP","issuer_ticker":"TLOG","issuer_name_source":null,"issuer_url":"/issuer/0001166285","owner_cik":null,"owner_name":"Clarus Lifesciences II, L.P.; HENNER DENNIS; LIPTAK ROBERT; Clarus Ventures II GP, L.P.; Simon Nicholas; GALAKATOS NICHOLAS; WHEELER KURT; Clarus Ventures II, LLC; STEINMETZ MICHAEL","owner_display_name":"Clarus Lifesciences II, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":176306.0,"shares_display":"176,306","price_per_share":0.17,"price_display":"0.17","price_state":"stated","total_value":29972.02,"total_display":"29,972.02","total_whole":"29,972","shares_owned_after":3963643.0,"shares_owned_after_display":"3,963,643","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-02-02","filed_date":"2016-02-02","scope":"insider"},{"id":2503787,"accession":"0001012975-16-000957","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001012975-16-000957","line_url":"/filing/0001012975-16-000957#line-2","is_derivative":false,"issuer_cik":"0001166285","issuer_name":"TETRALOGIC PHARMACEUTICALS CORP","issuer_ticker":"TLOG","issuer_name_source":null,"issuer_url":"/issuer/0001166285","owner_cik":null,"owner_name":"Clarus Lifesciences II, L.P.; HENNER DENNIS; LIPTAK ROBERT; Clarus Ventures II GP, L.P.; Simon Nicholas; GALAKATOS NICHOLAS; WHEELER KURT; Clarus Ventures II, LLC; STEINMETZ MICHAEL","owner_display_name":"Clarus Lifesciences II, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":140000.0,"shares_display":"140,000","price_per_share":0.2,"price_display":"0.20","price_state":"stated","total_value":28000.0,"total_display":"28,000.00","total_whole":"28,000","shares_owned_after":4139949.0,"shares_owned_after_display":"4,139,949","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-02-01","filed_date":"2016-02-02","scope":"insider"},{"id":2503780,"accession":"0001012975-16-000957","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001012975-16-000957","line_url":"/filing/0001012975-16-000957#line-1","is_derivative":false,"issuer_cik":"0001166285","issuer_name":"TETRALOGIC PHARMACEUTICALS CORP","issuer_ticker":"TLOG","issuer_name_source":null,"issuer_url":"/issuer/0001166285","owner_cik":null,"owner_name":"Clarus Lifesciences II, L.P.; HENNER DENNIS; LIPTAK ROBERT; Clarus Ventures II GP, L.P.; Simon Nicholas; GALAKATOS NICHOLAS; WHEELER KURT; Clarus Ventures II, LLC; STEINMETZ MICHAEL","owner_display_name":"Clarus Lifesciences II, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":52826.0,"shares_display":"52,826","price_per_share":0.26,"price_display":"0.26","price_state":"stated","total_value":13734.76,"total_display":"13,734.76","total_whole":"13,735","shares_owned_after":4279949.0,"shares_owned_after_display":"4,279,949","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-01-29","filed_date":"2016-02-02","scope":"insider"},{"id":2864990,"accession":"0001012975-16-000938","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001012975-16-000938","line_url":"/filing/0001012975-16-000938#line-3","is_derivative":false,"issuer_cik":"0001166285","issuer_name":"TETRALOGIC PHARMACEUTICALS CORP","issuer_ticker":"TLOG","issuer_name_source":null,"issuer_url":"/issuer/0001166285","owner_cik":null,"owner_name":"Clarus Lifesciences II, L.P.; HENNER DENNIS; WHEELER KURT; Simon Nicholas; Clarus Ventures II GP, L.P.; STEINMETZ MICHAEL; GALAKATOS NICHOLAS; LIPTAK ROBERT; Clarus Ventures II, LLC","owner_display_name":"Clarus Lifesciences II, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":32521.0,"shares_display":"32,521","price_per_share":0.26,"price_display":"0.26","price_state":"stated","total_value":8455.46,"total_display":"8,455.46","total_whole":"8,455","shares_owned_after":4332775.0,"shares_owned_after_display":"4,332,775","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-01-28","filed_date":"2016-01-28","scope":"insider"},{"id":2864986,"accession":"0001012975-16-000938","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001012975-16-000938","line_url":"/filing/0001012975-16-000938#line-2","is_derivative":false,"issuer_cik":"0001166285","issuer_name":"TETRALOGIC PHARMACEUTICALS CORP","issuer_ticker":"TLOG","issuer_name_source":null,"issuer_url":"/issuer/0001166285","owner_cik":null,"owner_name":"Clarus Lifesciences II, L.P.; HENNER DENNIS; WHEELER KURT; Simon Nicholas; Clarus Ventures II GP, L.P.; STEINMETZ MICHAEL; GALAKATOS NICHOLAS; LIPTAK ROBERT; Clarus Ventures II, LLC","owner_display_name":"Clarus Lifesciences II, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":209984.0,"shares_display":"209,984","price_per_share":0.27,"price_display":"0.27","price_state":"stated","total_value":56695.68,"total_display":"56,695.68","total_whole":"56,696","shares_owned_after":4365296.0,"shares_owned_after_display":"4,365,296","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-01-27","filed_date":"2016-01-28","scope":"insider"},{"id":2864979,"accession":"0001012975-16-000938","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001012975-16-000938","line_url":"/filing/0001012975-16-000938#line-1","is_derivative":false,"issuer_cik":"0001166285","issuer_name":"TETRALOGIC PHARMACEUTICALS CORP","issuer_ticker":"TLOG","issuer_name_source":null,"issuer_url":"/issuer/0001166285","owner_cik":null,"owner_name":"Clarus Lifesciences II, L.P.; HENNER DENNIS; WHEELER KURT; Simon Nicholas; Clarus Ventures II GP, L.P.; STEINMETZ MICHAEL; GALAKATOS NICHOLAS; LIPTAK ROBERT; Clarus Ventures II, LLC","owner_display_name":"Clarus Lifesciences II, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":69425.0,"shares_display":"69,425","price_per_share":0.3,"price_display":"0.30","price_state":"stated","total_value":20827.5,"total_display":"20,827.50","total_whole":"20,828","shares_owned_after":4575280.0,"shares_owned_after_display":"4,575,280","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-01-26","filed_date":"2016-01-28","scope":"insider"},{"id":3356650,"accession":"0001104659-16-089676","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001104659-16-089676","line_url":"/filing/0001104659-16-089676","is_derivative":false,"issuer_cik":"0001252522","issuer_name":"Ophthotech Corp.","issuer_ticker":"OPHT","issuer_name_source":null,"issuer_url":"/issuer/0001252522","owner_cik":"0001252522","owner_name":"GALAKATOS NICHOLAS","owner_display_name":"GALAKATOS NICHOLAS","owner_url":"/insider/0001252522","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":65.72366666666667,"price_display":"65.72","price_state":"stated","total_value":197171.0,"total_display":"197,171.00","total_whole":"197,171","shares_owned_after":5684.0,"shares_owned_after_display":"5,684","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-01-11","filed_date":"2016-01-13","scope":"insider","n_lines":4},{"id":8879396,"accession":"0001104659-15-084747","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001104659-15-084747","line_url":"/filing/0001104659-15-084747","is_derivative":false,"issuer_cik":"0001252522","issuer_name":"Ophthotech Corp.","issuer_ticker":"OPHT","issuer_name_source":null,"issuer_url":"/issuer/0001252522","owner_cik":"0001252522","owner_name":"GALAKATOS NICHOLAS","owner_display_name":"GALAKATOS NICHOLAS","owner_url":"/insider/0001252522","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":64.43622333333333,"price_display":"64.44","price_state":"stated","total_value":193308.67,"total_display":"193,308.67","total_whole":"193,309","shares_owned_after":7684.0,"shares_owned_after_display":"7,684","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-12-10","filed_date":"2015-12-14","scope":"insider","n_lines":4},{"id":8838996,"accession":"0001104659-15-080280","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-15-080280","line_url":"/filing/0001104659-15-080280","is_derivative":false,"issuer_cik":"0001252522","issuer_name":"Ophthotech Corp.","issuer_ticker":"OPHT","issuer_name_source":null,"issuer_url":"/issuer/0001252522","owner_cik":"0001252522","owner_name":"GALAKATOS NICHOLAS","owner_display_name":"GALAKATOS NICHOLAS","owner_url":"/insider/0001252522","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1500.0,"shares_display":"1,500","price_per_share":60.0,"price_display":"60.00","price_state":"stated","total_value":90000.0,"total_display":"90,000.00","total_whole":"90,000","shares_owned_after":9684.0,"shares_owned_after_display":"9,684","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-11-18","filed_date":"2015-11-19","scope":"insider","n_lines":2},{"id":8818190,"accession":"0001104659-15-078363","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001104659-15-078363","line_url":"/filing/0001104659-15-078363","is_derivative":false,"issuer_cik":"0001252522","issuer_name":"Ophthotech Corp.","issuer_ticker":"OPHT","issuer_name_source":null,"issuer_url":"/issuer/0001252522","owner_cik":"0001252522","owner_name":"GALAKATOS NICHOLAS","owner_display_name":"GALAKATOS NICHOLAS","owner_url":"/insider/0001252522","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1500.0,"shares_display":"1,500","price_per_share":58.69,"price_display":"58.69","price_state":"stated","total_value":88035.0,"total_display":"88,035.00","total_whole":"88,035","shares_owned_after":10684.0,"shares_owned_after_display":"10,684","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-11-10","filed_date":"2015-11-12","scope":"insider","n_lines":2},{"id":8818185,"accession":"0001104659-15-078363","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-15-078363","line_url":"/filing/0001104659-15-078363","is_derivative":false,"issuer_cik":"0001252522","issuer_name":"Ophthotech Corp.","issuer_ticker":"OPHT","issuer_name_source":null,"issuer_url":"/issuer/0001252522","owner_cik":"0001252522","owner_name":"GALAKATOS NICHOLAS","owner_display_name":"GALAKATOS NICHOLAS","owner_url":"/insider/0001252522","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1500.0,"shares_display":"1,500","price_per_share":60.0,"price_display":"60.00","price_state":"stated","total_value":90000.0,"total_display":"90,000.00","total_whole":"90,000","shares_owned_after":11684.0,"shares_owned_after_display":"11,684","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-11-09","filed_date":"2015-11-12","scope":"insider","n_lines":2},{"id":8172859,"accession":"0001104659-15-075825","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-15-075825","line_url":"/filing/0001104659-15-075825","is_derivative":false,"issuer_cik":"0001252522","issuer_name":"Ophthotech Corp.","issuer_ticker":"OPHT","issuer_name_source":null,"issuer_url":"/issuer/0001252522","owner_cik":"0001252522","owner_name":"GALAKATOS NICHOLAS","owner_display_name":"GALAKATOS NICHOLAS","owner_url":"/insider/0001252522","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1500.0,"shares_display":"1,500","price_per_share":54.0,"price_display":"54.00","price_state":"stated","total_value":81000.0,"total_display":"81,000.00","total_whole":"81,000","shares_owned_after":13184.0,"shares_owned_after_display":"13,184","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-11-02","filed_date":"2015-11-04","scope":"insider","n_lines":2},{"id":8596235,"accession":"0001104659-15-049022","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001104659-15-049022","line_url":"/filing/0001104659-15-049022#line-3","is_derivative":false,"issuer_cik":"0001252522","issuer_name":"CATABASIS PHARMACEUTICALS INC","issuer_ticker":"CATB","issuer_name_source":null,"issuer_url":"/issuer/0001252522","owner_cik":"0001252522","owner_name":"GALAKATOS NICHOLAS","owner_display_name":"GALAKATOS NICHOLAS","owner_url":"/insider/0001252522","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":376695.0,"shares_display":"376,695","price_per_share":12.0,"price_display":"12.00","price_state":"stated","total_value":4520340.0,"total_display":"4,520,340.00","total_whole":"4,520,340","shares_owned_after":2752488.0,"shares_owned_after_display":"2,752,488","ownership_form":"I","is_10b5_1":null,"transaction_date":"2015-06-30","filed_date":"2015-06-30","scope":"insider"},{"id":8355423,"accession":"0001012975-15-000491","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001012975-15-000491","line_url":"/filing/0001012975-15-000491#line-2","is_derivative":false,"issuer_cik":"0001249153","issuer_name":"Oxford Immunotec Global PLC","issuer_ticker":"OXFD","issuer_name_source":null,"issuer_url":"/issuer/0001249153","owner_cik":null,"owner_name":"Clarus Ventures I Management, L.P.; HENNER DENNIS; LIPTAK ROBERT; GALAKATOS NICHOLAS; Clarus Ventures I, LLC; WHEELER KURT; Clarus Lifesciences I, L.P.; Simon Nicholas","owner_display_name":"Clarus Ventures I Management, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":39701.0,"shares_display":"39,701","price_per_share":14.3,"price_display":"14.30","price_state":"stated","total_value":567724.3,"total_display":"567,724.30","total_whole":"567,724","shares_owned_after":2237377.0,"shares_owned_after_display":"2,237,377","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-06-16","filed_date":"2015-06-17","scope":"insider"},{"id":8355417,"accession":"0001012975-15-000491","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001012975-15-000491","line_url":"/filing/0001012975-15-000491#line-1","is_derivative":false,"issuer_cik":"0001249153","issuer_name":"Oxford Immunotec Global PLC","issuer_ticker":"OXFD","issuer_name_source":null,"issuer_url":"/issuer/0001249153","owner_cik":null,"owner_name":"Clarus Ventures I Management, L.P.; HENNER DENNIS; LIPTAK ROBERT; GALAKATOS NICHOLAS; Clarus Ventures I, LLC; WHEELER KURT; Clarus Lifesciences I, L.P.; Simon Nicholas","owner_display_name":"Clarus Ventures I Management, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1529.0,"shares_display":"1,529","price_per_share":14.27,"price_display":"14.27","price_state":"stated","total_value":21818.83,"total_display":"21,818.83","total_whole":"21,819","shares_owned_after":2277078.0,"shares_owned_after_display":"2,277,078","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-06-15","filed_date":"2015-06-17","scope":"insider"},{"id":8788735,"accession":"0001012975-15-000485","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001012975-15-000485","line_url":"/filing/0001012975-15-000485#line-2","is_derivative":false,"issuer_cik":"0001249153","issuer_name":"Oxford Immunotec Global PLC","issuer_ticker":"OXFD","issuer_name_source":null,"issuer_url":"/issuer/0001249153","owner_cik":null,"owner_name":"Clarus Lifesciences I, L.P.; LIPTAK ROBERT; GALAKATOS NICHOLAS; Simon Nicholas; Clarus Ventures I, LLC; Clarus Ventures I Management, L.P.; HENNER DENNIS; WHEELER KURT","owner_display_name":"Clarus Lifesciences I, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6430.0,"shares_display":"6,430","price_per_share":14.25,"price_display":"14.25","price_state":"stated","total_value":91627.5,"total_display":"91,627.50","total_whole":"91,628","shares_owned_after":2278607.0,"shares_owned_after_display":"2,278,607","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-06-12","filed_date":"2015-06-12","scope":"insider"},{"id":8788734,"accession":"0001012975-15-000485","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001012975-15-000485","line_url":"/filing/0001012975-15-000485#line-1","is_derivative":false,"issuer_cik":"0001249153","issuer_name":"Oxford Immunotec Global PLC","issuer_ticker":"OXFD","issuer_name_source":null,"issuer_url":"/issuer/0001249153","owner_cik":null,"owner_name":"Clarus Lifesciences I, L.P.; LIPTAK ROBERT; GALAKATOS NICHOLAS; Simon Nicholas; Clarus Ventures I, LLC; Clarus Ventures I Management, L.P.; HENNER DENNIS; WHEELER KURT","owner_display_name":"Clarus Lifesciences I, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25168.0,"shares_display":"25,168","price_per_share":14.27,"price_display":"14.27","price_state":"stated","total_value":359147.36,"total_display":"359,147.36","total_whole":"359,147","shares_owned_after":2285037.0,"shares_owned_after_display":"2,285,037","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-06-11","filed_date":"2015-06-12","scope":"insider"},{"id":8913883,"accession":"0001012975-15-000479","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001012975-15-000479","line_url":"/filing/0001012975-15-000479#line-3","is_derivative":false,"issuer_cik":"0001249153","issuer_name":"Oxford Immunotec Global PLC","issuer_ticker":"OXFD","issuer_name_source":null,"issuer_url":"/issuer/0001249153","owner_cik":null,"owner_name":"WHEELER KURT; LIPTAK ROBERT; Simon Nicholas; GALAKATOS NICHOLAS; Clarus Ventures I, LLC; Clarus Ventures I Management, L.P.; HENNER DENNIS; Clarus Lifesciences I, L.P.","owner_display_name":"WHEELER KURT","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8987.0,"shares_display":"8,987","price_per_share":14.32,"price_display":"14.32","price_state":"stated","total_value":128693.84,"total_display":"128,693.84","total_whole":"128,694","shares_owned_after":2310205.0,"shares_owned_after_display":"2,310,205","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-06-10","filed_date":"2015-06-10","scope":"insider"},{"id":8913880,"accession":"0001012975-15-000479","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001012975-15-000479","line_url":"/filing/0001012975-15-000479#line-2","is_derivative":false,"issuer_cik":"0001249153","issuer_name":"Oxford Immunotec Global PLC","issuer_ticker":"OXFD","issuer_name_source":null,"issuer_url":"/issuer/0001249153","owner_cik":null,"owner_name":"WHEELER KURT; LIPTAK ROBERT; Simon Nicholas; GALAKATOS NICHOLAS; Clarus Ventures I, LLC; Clarus Ventures I Management, L.P.; HENNER DENNIS; Clarus Lifesciences I, L.P.","owner_display_name":"WHEELER KURT","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13000.0,"shares_display":"13,000","price_per_share":14.26,"price_display":"14.26","price_state":"stated","total_value":185380.0,"total_display":"185,380.00","total_whole":"185,380","shares_owned_after":2319192.0,"shares_owned_after_display":"2,319,192","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-06-09","filed_date":"2015-06-10","scope":"insider"},{"id":8913878,"accession":"0001012975-15-000479","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001012975-15-000479","line_url":"/filing/0001012975-15-000479#line-1","is_derivative":false,"issuer_cik":"0001249153","issuer_name":"Oxford Immunotec Global PLC","issuer_ticker":"OXFD","issuer_name_source":null,"issuer_url":"/issuer/0001249153","owner_cik":null,"owner_name":"WHEELER KURT; LIPTAK ROBERT; Simon Nicholas; GALAKATOS NICHOLAS; Clarus Ventures I, LLC; Clarus Ventures I Management, L.P.; HENNER DENNIS; Clarus Lifesciences I, L.P.","owner_display_name":"WHEELER KURT","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2662.0,"shares_display":"2,662","price_per_share":14.25,"price_display":"14.25","price_state":"stated","total_value":37933.5,"total_display":"37,933.50","total_whole":"37,934","shares_owned_after":2332192.0,"shares_owned_after_display":"2,332,192","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-06-08","filed_date":"2015-06-10","scope":"insider"},{"id":8171549,"accession":"0001012975-15-000473","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001012975-15-000473","line_url":"/filing/0001012975-15-000473#line-3","is_derivative":false,"issuer_cik":"0001249153","issuer_name":"Oxford Immunotec Global PLC","issuer_ticker":"OXFD","issuer_name_source":null,"issuer_url":"/issuer/0001249153","owner_cik":null,"owner_name":"Clarus Ventures I, LLC; Clarus Lifesciences I, L.P.; WHEELER KURT; LIPTAK ROBERT; GALAKATOS NICHOLAS; Simon Nicholas; Clarus Ventures I Management, L.P.; HENNER DENNIS","owner_display_name":"Clarus Ventures I, LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10450.0,"shares_display":"10,450","price_per_share":14.32,"price_display":"14.32","price_state":"stated","total_value":149644.0,"total_display":"149,644.00","total_whole":"149,644","shares_owned_after":2334854.0,"shares_owned_after_display":"2,334,854","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-06-03","filed_date":"2015-06-03","scope":"insider"},{"id":8171546,"accession":"0001012975-15-000473","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001012975-15-000473","line_url":"/filing/0001012975-15-000473#line-2","is_derivative":false,"issuer_cik":"0001249153","issuer_name":"Oxford Immunotec Global PLC","issuer_ticker":"OXFD","issuer_name_source":null,"issuer_url":"/issuer/0001249153","owner_cik":null,"owner_name":"Clarus Ventures I, LLC; Clarus Lifesciences I, L.P.; WHEELER KURT; LIPTAK ROBERT; GALAKATOS NICHOLAS; Simon Nicholas; Clarus Ventures I Management, L.P.; HENNER DENNIS","owner_display_name":"Clarus Ventures I, LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11014.0,"shares_display":"11,014","price_per_share":14.25,"price_display":"14.25","price_state":"stated","total_value":156949.5,"total_display":"156,949.50","total_whole":"156,950","shares_owned_after":2345304.0,"shares_owned_after_display":"2,345,304","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-06-02","filed_date":"2015-06-03","scope":"insider"},{"id":8171544,"accession":"0001012975-15-000473","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001012975-15-000473","line_url":"/filing/0001012975-15-000473#line-1","is_derivative":false,"issuer_cik":"0001249153","issuer_name":"Oxford Immunotec Global PLC","issuer_ticker":"OXFD","issuer_name_source":null,"issuer_url":"/issuer/0001249153","owner_cik":null,"owner_name":"Clarus Ventures I, LLC; Clarus Lifesciences I, L.P.; WHEELER KURT; LIPTAK ROBERT; GALAKATOS NICHOLAS; Simon Nicholas; Clarus Ventures I Management, L.P.; HENNER DENNIS","owner_display_name":"Clarus Ventures I, LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15010.0,"shares_display":"15,010","price_per_share":14.29,"price_display":"14.29","price_state":"stated","total_value":214492.9,"total_display":"214,492.90","total_whole":"214,493","shares_owned_after":2356318.0,"shares_owned_after_display":"2,356,318","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-06-01","filed_date":"2015-06-03","scope":"insider"},{"id":8355363,"accession":"0001012975-15-000242","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001012975-15-000242","line_url":"/filing/0001012975-15-000242#line-2","is_derivative":false,"issuer_cik":"0001249153","issuer_name":"Oxford Immunotec Global PLC","issuer_ticker":"OXFD","issuer_name_source":null,"issuer_url":"/issuer/0001249153","owner_cik":null,"owner_name":"LIPTAK ROBERT; GALAKATOS NICHOLAS; Clarus Lifesciences I, L.P.; WHEELER KURT; Clarus Ventures I Management, L.P.; HENNER DENNIS; Simon Nicholas; Clarus Ventures I, LLC","owner_display_name":"LIPTAK ROBERT","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":26300.0,"shares_display":"26,300","price_per_share":14.44,"price_display":"14.44","price_state":"stated","total_value":379772.0,"total_display":"379,772.00","total_whole":"379,772","shares_owned_after":2371328.0,"shares_owned_after_display":"2,371,328","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-03-23","filed_date":"2015-03-24","scope":"insider"},{"id":8355356,"accession":"0001012975-15-000242","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001012975-15-000242","line_url":"/filing/0001012975-15-000242#line-1","is_derivative":false,"issuer_cik":"0001249153","issuer_name":"Oxford Immunotec Global PLC","issuer_ticker":"OXFD","issuer_name_source":null,"issuer_url":"/issuer/0001249153","owner_cik":null,"owner_name":"LIPTAK ROBERT; GALAKATOS NICHOLAS; Clarus Lifesciences I, L.P.; WHEELER KURT; Clarus Ventures I Management, L.P.; HENNER DENNIS; Simon Nicholas; Clarus Ventures I, LLC","owner_display_name":"LIPTAK ROBERT","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":27115.0,"shares_display":"27,115","price_per_share":14.53,"price_display":"14.53","price_state":"stated","total_value":393980.95,"total_display":"393,980.95","total_whole":"393,981","shares_owned_after":2397628.0,"shares_owned_after_display":"2,397,628","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-03-20","filed_date":"2015-03-24","scope":"insider"},{"id":8516808,"accession":"0001012975-15-000238","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001012975-15-000238","line_url":"/filing/0001012975-15-000238#line-3","is_derivative":false,"issuer_cik":"0001249153","issuer_name":"Oxford Immunotec Global PLC","issuer_ticker":"OXFD","issuer_name_source":null,"issuer_url":"/issuer/0001249153","owner_cik":null,"owner_name":"GALAKATOS NICHOLAS; Simon Nicholas; Clarus Ventures I, LLC; LIPTAK ROBERT; Clarus Lifesciences I, L.P.; Clarus Ventures I Management, L.P.; HENNER DENNIS; WHEELER KURT","owner_display_name":"GALAKATOS NICHOLAS","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":50012.0,"shares_display":"50,012","price_per_share":14.61,"price_display":"14.61","price_state":"stated","total_value":730675.32,"total_display":"730,675.32","total_whole":"730,675","shares_owned_after":2424743.0,"shares_owned_after_display":"2,424,743","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-03-19","filed_date":"2015-03-19","scope":"insider"},{"id":8516804,"accession":"0001012975-15-000238","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001012975-15-000238","line_url":"/filing/0001012975-15-000238#line-2","is_derivative":false,"issuer_cik":"0001249153","issuer_name":"Oxford Immunotec Global PLC","issuer_ticker":"OXFD","issuer_name_source":null,"issuer_url":"/issuer/0001249153","owner_cik":null,"owner_name":"GALAKATOS NICHOLAS; Simon Nicholas; Clarus Ventures I, LLC; LIPTAK ROBERT; Clarus Lifesciences I, L.P.; Clarus Ventures I Management, L.P.; HENNER DENNIS; WHEELER KURT","owner_display_name":"GALAKATOS NICHOLAS","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":14.68,"price_display":"14.68","price_state":"stated","total_value":367000.0,"total_display":"367,000.00","total_whole":"367,000","shares_owned_after":2474755.0,"shares_owned_after_display":"2,474,755","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-03-18","filed_date":"2015-03-19","scope":"insider"},{"id":8516797,"accession":"0001012975-15-000238","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001012975-15-000238","line_url":"/filing/0001012975-15-000238#line-1","is_derivative":false,"issuer_cik":"0001249153","issuer_name":"Oxford Immunotec Global PLC","issuer_ticker":"OXFD","issuer_name_source":null,"issuer_url":"/issuer/0001249153","owner_cik":null,"owner_name":"GALAKATOS NICHOLAS; Simon Nicholas; Clarus Ventures I, LLC; LIPTAK ROBERT; Clarus Lifesciences I, L.P.; Clarus Ventures I Management, L.P.; HENNER DENNIS; WHEELER KURT","owner_display_name":"GALAKATOS NICHOLAS","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":79307.0,"shares_display":"79,307","price_per_share":14.67,"price_display":"14.67","price_state":"stated","total_value":1163433.69,"total_display":"1,163,433.69","total_whole":"1,163,434","shares_owned_after":2499755.0,"shares_owned_after_display":"2,499,755","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-03-17","filed_date":"2015-03-19","scope":"insider"},{"id":8856842,"accession":"0001012975-15-000017","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001012975-15-000017","line_url":"/filing/0001012975-15-000017#line-1","is_derivative":false,"issuer_cik":"0001166285","issuer_name":"AERIE PHARMACEUTICALS INC","issuer_ticker":"AERI","issuer_name_source":null,"issuer_url":"/issuer/0001166285","owner_cik":null,"owner_name":"Simon Nicholas; WHEELER KURT; Clarus Ventures II GP, L.P.; Clarus Ventures II, LLC; STEINMETZ MICHAEL; Clarus Lifesciences II, L.P.; GALAKATOS NICHOLAS; LIPTAK ROBERT; HENNER DENNIS","owner_display_name":"Simon Nicholas","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":175000.0,"shares_display":"175,000","price_per_share":31.11,"price_display":"31.11","price_state":"stated","total_value":5444250.0,"total_display":"5,444,250.00","total_whole":"5,444,250","shares_owned_after":3324259.0,"shares_owned_after_display":"3,324,259","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-01-08","filed_date":"2015-01-12","scope":"insider"},{"id":8171532,"accession":"0001012975-15-000003","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001012975-15-000003","line_url":"/filing/0001012975-15-000003","is_derivative":false,"issuer_cik":"0001166285","issuer_name":"AERIE PHARMACEUTICALS INC","issuer_ticker":"AERI","issuer_name_source":null,"issuer_url":"/issuer/0001166285","owner_cik":null,"owner_name":"STEINMETZ MICHAEL; Simon Nicholas; HENNER DENNIS; WHEELER KURT; Clarus Ventures II GP, L.P.; Clarus Ventures II, LLC; Clarus Lifesciences II, L.P.; LIPTAK ROBERT; GALAKATOS NICHOLAS","owner_display_name":"STEINMETZ MICHAEL","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":23620.0,"shares_display":"23,620","price_per_share":30.860008467400508,"price_display":"30.86","price_state":"stated","total_value":728913.4,"total_display":"728,913.40","total_whole":"728,913","shares_owned_after":3509459.0,"shares_owned_after_display":"3,509,459","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-01-05","filed_date":"2015-01-06","scope":"insider","n_lines":2},{"id":6925879,"accession":"0001012975-14-000835","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001012975-14-000835","line_url":"/filing/0001012975-14-000835#line-2","is_derivative":false,"issuer_cik":"0001166285","issuer_name":"AERIE PHARMACEUTICALS INC","issuer_ticker":"AERI","issuer_name_source":null,"issuer_url":"/issuer/0001166285","owner_cik":null,"owner_name":"Simon Nicholas; WHEELER KURT; Clarus Ventures II GP, L.P.; Clarus Ventures II, LLC; STEINMETZ MICHAEL; Clarus Lifesciences II, L.P.; GALAKATOS NICHOLAS; LIPTAK ROBERT; HENNER DENNIS","owner_display_name":"Simon Nicholas","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6214.0,"shares_display":"6,214","price_per_share":30.03,"price_display":"30.03","price_state":"stated","total_value":186606.42,"total_display":"186,606.42","total_whole":"186,606","shares_owned_after":3522879.0,"shares_owned_after_display":"3,522,879","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-12-29","filed_date":"2014-12-30","scope":"insider"}],"collapsed":true,"next_cursor":"2014-12-29|6925879","ledger_fault":false,"count":{"value":32,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":7,"open_market":true},{"code":"S","label":"Open-market sale","n":25,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":32},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001724344","name":"Entasis Therapeutics Holdings Inc.","url":"/issuer/0001724344","role":"Director, Ten percent owner","n_filings":1,"first_seen":"2018-10-02","last_seen":"2018-10-02"},{"type":"issuer","type_label":"ISSUER","cik":"0001401708","name":"NanoString Technologies Inc","url":"/issuer/0001401708","role":"Director, Ten percent owner","n_filings":1,"first_seen":"2018-09-19","last_seen":"2018-09-19"},{"type":"issuer","type_label":"ISSUER","cik":"0001667633","name":"Forty Seven, Inc.","url":"/issuer/0001667633","role":"Ten percent owner","n_filings":1,"first_seen":"2018-07-02","last_seen":"2018-07-02"},{"type":"issuer","type_label":"ISSUER","cik":"0001361248","name":"TETRALOGIC PHARMACEUTICALS CORP","url":"/issuer/0001361248","role":"Ten percent owner","n_filings":5,"first_seen":"2013-12-19","last_seen":"2016-02-10"},{"type":"issuer","type_label":"ISSUER","cik":"0001410939","name":"Ophthotech Corp.","url":"/issuer/0001410939","role":"Director, Ten percent owner","n_filings":8,"first_seen":"2013-11-20","last_seen":"2016-01-13"},{"type":"issuer","type_label":"ISSUER","cik":"0001454789","name":"CATABASIS PHARMACEUTICALS INC","url":"/issuer/0001454789","role":"Director, Ten percent owner","n_filings":1,"first_seen":"2015-06-30","last_seen":"2015-06-30"},{"type":"issuer","type_label":"ISSUER","cik":"0001586049","name":"Oxford Immunotec Global PLC","url":"/issuer/0001586049","role":"Ten percent owner","n_filings":6,"first_seen":"2015-03-19","last_seen":"2015-06-17"},{"type":"issuer","type_label":"ISSUER","cik":"0001337553","name":"AERIE PHARMACEUTICALS INC","url":"/issuer/0001337553","role":"Ten percent owner","n_filings":6,"first_seen":"2013-10-28","last_seen":"2015-01-30"},{"type":"issuer","type_label":"ISSUER","cik":"0001269021","name":"PORTOLA PHARMACEUTICALS INC","url":"/issuer/0001269021","role":"Director","n_filings":1,"first_seen":"2014-06-11","last_seen":"2014-06-11"},{"type":"issuer","type_label":"ISSUER","cik":"0001237831","name":"GLOBUS MEDICAL INC","url":"/issuer/0001237831","role":"Other","n_filings":1,"first_seen":"2012-08-10","last_seen":"2012-08-10"},{"type":"issuer","type_label":"ISSUER","cik":"0001339455","name":"Somaxon Pharmaceuticals, Inc.","url":"/issuer/0001339455","role":"Ten percent owner","n_filings":13,"first_seen":"2005-12-22","last_seen":"2012-07-10"},{"type":"issuer","type_label":"ISSUER","cik":"0001070336","name":"ACHILLION PHARMACEUTICALS INC","url":"/issuer/0001070336","role":"Ten percent owner","n_filings":8,"first_seen":"2008-09-09","last_seen":"2012-06-04"},{"type":"issuer","type_label":"ISSUER","cik":"0001135906","name":"Zalicus Inc.","url":"/issuer/0001135906","role":"Ten percent owner","n_filings":10,"first_seen":"2011-09-28","last_seen":"2011-10-28"},{"type":"issuer","type_label":"ISSUER","cik":"0001375151","name":"ZOGENIX, INC.","url":"/issuer/0001375151","role":"Ten percent owner","n_filings":2,"first_seen":"2010-11-30","last_seen":"2011-09-20"},{"type":"issuer","type_label":"ISSUER","cik":"0000858803","name":"AVANIR PHARMACEUTICALS, INC.","url":"/issuer/0000858803","role":"Ten percent owner","n_filings":5,"first_seen":"2010-07-15","last_seen":"2010-11-10"},{"type":"issuer","type_label":"ISSUER","cik":"0001326190","name":"PHARMATHENE, INC","url":"/issuer/0001326190","role":"Ten percent owner","n_filings":3,"first_seen":"2007-08-07","last_seen":"2010-11-05"},{"type":"issuer","type_label":"ISSUER","cik":"0001097136","name":"SENORX INC","url":"/issuer/0001097136","role":"Ten percent owner","n_filings":3,"first_seen":"2010-04-26","last_seen":"2010-06-29"},{"type":"issuer","type_label":"ISSUER","cik":"0000755806","name":"PONIARD PHARMACEUTICALS, INC.","url":"/issuer/0000755806","role":"Ten percent owner","n_filings":2,"first_seen":"2007-05-01","last_seen":"2009-11-09"},{"type":"issuer","type_label":"ISSUER","cik":"0001371217","name":"EnteroMedics Inc","url":"/issuer/0001371217","role":"Ten percent owner","n_filings":2,"first_seen":"2007-11-21","last_seen":"2009-02-25"},{"type":"issuer","type_label":"ISSUER","cik":"0001410064","name":"ARYx Therapeutics, Inc.","url":"/issuer/0001410064","role":"Ten percent owner","n_filings":2,"first_seen":"2007-11-13","last_seen":"2008-11-17"},{"type":"issuer","type_label":"ISSUER","cik":"0001053221","name":"METABASIS THERAPEUTICS INC","url":"/issuer/0001053221","role":"Ten percent owner","n_filings":3,"first_seen":"2004-06-21","last_seen":"2008-04-18"},{"type":"issuer","type_label":"ISSUER","cik":"0001301081","name":"Pharmasset Inc","url":"/issuer/0001301081","role":"Ten percent owner","n_filings":4,"first_seen":"2007-05-04","last_seen":"2008-02-22"},{"type":"issuer","type_label":"ISSUER","cik":"0001127393","name":"HEMOSENSE INC","url":"/issuer/0001127393","role":"Ten percent owner","n_filings":2,"first_seen":"2005-07-06","last_seen":"2007-09-14"},{"type":"issuer","type_label":"ISSUER","cik":"0001274563","name":"HELICOS BIOSCIENCES CORP","url":"/issuer/0001274563","role":"Ten percent owner","n_filings":1,"first_seen":"2007-05-31","last_seen":"2007-05-31"},{"type":"issuer","type_label":"ISSUER","cik":"0001125294","name":"CRYOCOR INC","url":"/issuer/0001125294","role":"Ten percent owner","n_filings":2,"first_seen":"2005-07-14","last_seen":"2007-04-25"},{"type":"issuer","type_label":"ISSUER","cik":"0001138812","name":"COTHERIX INC","url":"/issuer/0001138812","role":"Ten percent owner","n_filings":3,"first_seen":"2004-10-21","last_seen":"2005-10-19"},{"type":"issuer","type_label":"ISSUER","cik":"0001262175","name":"TERCICA INC","url":"/issuer/0001262175","role":"Ten percent owner","n_filings":4,"first_seen":"2004-03-23","last_seen":"2005-09-12"},{"type":"issuer","type_label":"ISSUER","cik":"0001145404","name":"CRITICAL THERAPEUTICS INC","url":"/issuer/0001145404","role":"Director, Ten percent owner","n_filings":3,"first_seen":"2004-06-02","last_seen":"2005-06-22"},{"type":"issuer","type_label":"ISSUER","cik":"0001173657","name":"BARRIER THERAPEUTICS INC","url":"/issuer/0001173657","role":"Ten percent owner, Other","n_filings":4,"first_seen":"2004-05-05","last_seen":"2005-03-03"},{"type":"issuer","type_label":"ISSUER","cik":"0001034842","name":"RIGEL PHARMACEUTICALS INC","url":"/issuer/0001034842","role":"Ten percent owner","n_filings":17,"first_seen":"2004-02-23","last_seen":"2004-09-02"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001252522","retrieved_at":"2026-08-23T23:09:21+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}